Sanctuary Advisors LLC Sells 41,736 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Sanctuary Advisors LLC reduced its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 94.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,358 shares of the company’s stock after selling 41,736 shares during the quarter. Sanctuary Advisors LLC’s holdings in VanEck Pharmaceutical ETF were worth $209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Townsquare Capital LLC increased its position in shares of VanEck Pharmaceutical ETF by 3.8% in the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after acquiring an additional 130 shares during the period. FMR LLC increased its position in shares of VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after buying an additional 212 shares during the period. Beck Capital Management LLC boosted its position in VanEck Pharmaceutical ETF by 1.5% during the 2nd quarter. Beck Capital Management LLC now owns 21,274 shares of the company’s stock valued at $1,946,000 after acquiring an additional 317 shares in the last quarter. Assetmark Inc. grew its holdings in shares of VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock worth $617,000 after acquiring an additional 354 shares during the period. Finally, Harbour Investments Inc. raised its holdings in VanEck Pharmaceutical ETF by 16.6% in the third quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after purchasing an additional 488 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH opened at $87.17 on Monday. VanEck Pharmaceutical ETF has a fifty-two week low of $81.03 and a fifty-two week high of $99.51. The stock has a market cap of $644.19 million, a PE ratio of 21.04 and a beta of 0.72. The firm’s 50-day simple moving average is $89.54 and its two-hundred day simple moving average is $92.72.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a dividend, which will be paid on Monday, December 30th. Investors of record on Friday, December 27th will be issued a $0.411 dividend. The ex-dividend date of this dividend is Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.